Keywords: fda, clears, mannkind, mkc1106-pp, immunotherapy, ind, drug

FDA clears MannKind MKC1106-PP immunotherapy IND

Article | 04 December 2006

Print This

US drug discovery firm MannKind Corp says that an Investigational New Drug application for its range of MKC1106-PP-based immunotherapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in